Search Results 141-150 of 16342 for immunothérapie effets secondaires
This open-label, exploratory study is designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or combinations ...
Immunotherapy with monoclonal antibodies such as ipilimumab and nivolumab may help the body's immune system attack the cancer and may interfere with the ability ...
This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...
The purpose of this study is to evaluate the long-term safety in patients previously treated with Medeor cellular immunotherapy products in a Medeor parent ...
The research of Marion R. Curtis, Ph.D., in her Immunometabolism and Cancer Immunology Lab at Mayo Clinic focuses on immunotherapy and tumor antigens in ...
Anti-cancer chemotherapy, radiotherapy, immunotherapy, or investigational agents ≤14 days of first dose of study drug; Major surgery ≤28 days before start ...
Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...
Immunotherapy. You can "train" your immune system not to be sensitive to an allergen. Immunotherapy is delivered through a series of allergy shots. One to 2 ...
Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...
They, or another member of the care team, will give you information about who to call with questions or concerns. Immunotherapy for allergies. Allergy ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.